InvestorsHub Logo
Followers 826
Posts 119569
Boards Moderated 14
Alias Born 09/05/2002

Re: DewDiligence post# 199

Wednesday, 09/06/2017 8:42:01 AM

Wednesday, September 06, 2017 8:42:01 AM

Post# of 7254
RVNC adds ex-CEO of ZLTQ to BoD:

https://finance.yahoo.com/news/revance-appoints-mark-foley-board-113000252.html

Revance Therapeutics…today announced that Mark Foley has been appointed to Revance’s Board of Directors, effective September 5, 2017.

Mr. Foley most recently served as Chairman, President and CEO of ZELTIQ* Aesthetics (ZLTQ). He brings more than 25 years of operational and investment experience in the healthcare arena, and earlier this year led the sale of ZELTIQ to Allergan for $2.5 billion.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RVNC News